Skip to main content

Search

Reset all filters
49 Result(s)
Sort by

Oncology Translational Science

Oncology Translational Science

Discover how Boehringer Ingelheim leverages translational science to bridge pre-clinical research and clinical development, enhancing patient outcomes in oncology. Learn about our patient-centric strategies, biomarker discovery, and collaborative efforts
Making sustainable medicines through eco-design

Making sustainable medicines through eco-design

Our goal is to minimize the environmental footprint of our medicines through integration of eco-design and green chemistry across the entire lifecycle
Drug discovery Boehringer Ingelheim

Drug discovery Boehringer Ingelheim

Every day, scientists at Boehringer Ingelheim embark on a journey. It is a journey that can take up to 15 years and requires significant investment. Only a tiny proportion of these journeys are successful.
Embracing diversity in clinical trials: A global mandate

Embracing diversity in clinical trials: A global mandate

Have you ever wondered why medicines work differently for different people? Each patient is unique. By embracing diversity in clinical trials, we enable more equitable and inclusive healthcare.
Biotherapeutics Discovery

Biotherapeutics Discovery

Our committed team of scientists are using all their experience and knowledge to forge new research paths, engineer new molecules and do whatever it takes to make sure that no patient is left behind in our search for the next breakthrough.
More Health: Overview

More Health: Overview

As a company that operates at the intersection of human and veterinary medicine, we have unique opportunities to advocate for disadvantaged populations.
Science & Innovation

Science & Innovation

Innovation Wir verbessern die Gesundheit und die Lebensqualität von Patienten. Das ist seit 130 Jahren das zentrale Ziel des forschenden Pharmaunternehmens Boehringer Ingelheim.
Science & Innovation

Science & Innovation

We improve patients' health and quality of life. This has been the central goal of the research-based pharmaceutical company Boehringer Ingelheim for 130 years.
Open Innovation Boehringer Ingelheim

Open Innovation Boehringer Ingelheim

Learn more about how we’re working across the innovation community to advance research and accelerate the development of new medicines
Improving Access to Healthcare

Improving Access to Healthcare

According to the UN Sustainable Development Goals, nearly half of the world's population lacks access to basic health care.